365 related articles for article (PubMed ID: 3160933)
1. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
Santoli D; Francis MK; Matera L
Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
[TBL] [Abstract][Full Text] [Related]
2. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.
Matera L; Francis MK; Herlyn M; Trucco M; Santoli D
Nat Immun Cell Growth Regul; 1985; 4(2):90-102. PubMed ID: 3160934
[TBL] [Abstract][Full Text] [Related]
3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
4. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
5. Tac antigen-positive T cells activated in autologous mixed lymphocyte reaction regulate the generation of killer T cells against hapten-modified autologous cells.
Kumagai S; Namiuchi S; Ozaki S; Sano H; Tsubata T; Suginoshita T; Imura H
J Immunol; 1985 Feb; 134(2):711-7. PubMed ID: 2981269
[TBL] [Abstract][Full Text] [Related]
6. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
Strassmann G; Bach FH; Zarling JM
J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
[TBL] [Abstract][Full Text] [Related]
7. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
8. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.
Engleman EG; Charron DJ; Benike CJ; Stewart GJ
J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944
[TBL] [Abstract][Full Text] [Related]
9. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
Yoshizawa K; Yano A
J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
[TBL] [Abstract][Full Text] [Related]
10. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
Engleman EG; Benike CJ; Grumet FC; Evans RL
J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
Warren HS
J Immunol; 1984 Jun; 132(6):2888-94. PubMed ID: 6233364
[TBL] [Abstract][Full Text] [Related]
12. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
13. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
[TBL] [Abstract][Full Text] [Related]
14. The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR.
Huber C; Fink U; Leibold W; Schmalzl F; Peterson PA; Klareskog L; Braunsteiner H
J Immunol; 1981 Aug; 127(2):726-31. PubMed ID: 6454727
[TBL] [Abstract][Full Text] [Related]
15. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
16. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
18. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
19. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]